Gemini bioproducts:1110293 [20-003859] - this fetal bovine serum is required to culture primary cells and cell line that are done in ombrello lab.
Ended Awarded Last action
- Contract number
- 75N92B20F00001
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,240
Award facts
- Contract value 100% obligated
- $10,239.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$64 | |
| Original award | $10,304 |
About this award
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a Blanket Purchase Agreement call valued at $10,239.66 to Gemini Bioproducts LLC for the supply of fetal bovine serum required to culture primary cells and cell lines used in the Ombrello Lab. The contract was awarded on August 27, 2020, with an ultimate completion date of March 26, 2025, and operates under a firm fixed-price structure with no set-aside designation. Gemini Bioproducts, a West Sacramento, California-based manufacturer of cell culture products and scientific reagents, was selected as the prime contractor for this procurement.
This award represents a call against a larger $100 million single-award Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations, through which Gemini Bioproducts provides cell culture products, sera, antibiotics, media, reagents, and blood-related products to federal agencies. The vendor has established itself as a key supplier to the National Institutes of Health ecosystem since its registration in SAM.gov in 2001, with a demonstrated track record of providing critical biological materials to support federal biomedical research initiatives.
Quick answers
Who was awarded contract 75N92B20F00001?
75N92B20F00001 was awarded to Gemini Bioproducts LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 27, 2020.
How much is contract 75N92B20F00001 worth?
The government has obligated $10,240 on 75N92B20F00001.
Is contract 75N92B20F00001 an order under another contract?
Yes. 75N92B20F00001 is a BPA call under HHSN263201500189B, a blanket purchase agreement.
Was contract 75N92B20F00001 competed?
The extent of competition for 75N92B20F00001 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award